NCT06641583

Brief Summary

The goal of this clinical trial is to learn if LEGO therapy can enhance social skills in children aged 10-14 diagnosed with high-functioning Autism Spectrum Disorder. The main questions it aims to answer are: Does LEGO therapy improve social communication and interaction skills in children with Autism Spectrum Disorder? Do children show behavioral improvements in social skills after participating in LEGO therapy? Researchers will compare children receiving LEGO therapy to a control group (who will not receive LEGO therapy but continue their usual treatments) to see if LEGO therapy leads to greater improvements in social skills. Participants will: Complete behavioral tasks, including a LEGO construction test, at the beginning (T0) and after 3 months (T1). Attend weekly LEGO therapy sessions for 90 minutes, over the course of 3 months (12 sessions). Complete questionnaires about social behaviors, both parents and children, at T0 and T1.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
50

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Sep 2024

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 20, 2024

Completed
19 days until next milestone

First Submitted

Initial submission to the registry

October 9, 2024

Completed
6 days until next milestone

First Posted

Study publicly available on registry

October 15, 2024

Completed
1.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2025

Completed
Last Updated

April 1, 2026

Status Verified

March 1, 2026

Enrollment Period

1.3 years

First QC Date

October 9, 2024

Last Update Submit

March 27, 2026

Conditions

Keywords

Autism Spectrum DisorderADHD

Outcome Measures

Primary Outcomes (1)

  • Social Skills

    1\. Social Skills Improvement System RatingScales (SSiS) (Gresham \& Elliott, 2008). The Social Skills Improvement System-Rating Scales (SSIS-RS; Gresham \& Elliott, 2008) is a multi-rater (teacher, parent/caregiver, and student) series of rating scales that documents the frequency of social skills and competing problem behaviors. It is a revision of the Social Skills Rating System (SSRS; Gresham \& Elliott, 1990). The SSIS-RS assess three domains of social skills, problem behaviors, and academic competence. All forms include common social skills in multiple subdomains: communication, cooperation, assertion, responsibility, empathy, engagement, and self-control. The subscales are grouped beneath Problem Behavior and Social Skills domains. Higher scores mean a better.

    From enrollment (T0) to the end of treatment at 12 weeks

Secondary Outcomes (1)

  • Autistic symtoms

    From enrollment (T0) to the end of treatment at 12 weeks

Study Arms (2)

Exprimental

EXPERIMENTAL

Experimental Group: This group will consist of children aged 10-14 diagnosed with high-functioning Autism Spectrum Disorder (ASD). These children will participate in LEGO therapy sessions once a week for 90 minutes over the course of 3 months (12 sessions total). The goal is to evaluate how LEGO therapy influences their social skills and behavior.

Behavioral: LEGO

Control

ACTIVE COMPARATOR

Control Group: This group will also consist of children aged 10-14 diagnosed with high-functioning ASD. However, these children will not receive LEGO therapy. Instead, they will continue their usual treatments in their local settings without participating in the LEGO therapy sessions. This group's outcomes will be compared with the experimental group to assess the effectiveness of LEGO therapy.

Other: Controllo

Interventions

LEGOBEHAVIORAL

The LEGO Therapy intervention in this clinical trial is designed to enhance social skills in children with high-functioning Autism Spectrum Disorder (ASD). The intervention involves the following components: Group Sessions: The therapy will be conducted in small groups of three children of the same age (10-14 years) with a diagnosis of high-functioning ASD. The sessions are designed to foster collaboration and social interaction between the participants. Duration: The intervention will last for 3 months, consisting of 12 sessions, with each session lasting 90 minutes. Sessions will take place once a week at the IRCCS Fondazione Stella Maris. Supervision: The groups will be supervised by trained professionals specializing in neurodevelopmental disorders, ensuring that the therapy is structured and supportive of each child\'s individual needs. Therapy Structure: During the sessions, children will engage in LEGO-based tasks, where they collaborate to build LEGO models.

Exprimental

This group will also consist of children aged 10-14 diagnosed with high-functioning ASD. However, these children will not receive LEGO therapy. Instead, they will continue their usual treatments in their local settings without participating in the LEGO therapy sessions. This group\'s outcomes will be compared with the experimental group to assess the effectiveness of LEGO therapy.

Control

Eligibility Criteria

Age10 Years - 14 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • age between 10 and 14 years;
  • clinical diagnosis of Autism Spectrum Disorder according to ICD-10 (WHO, 1992);
  • intellectual level in the normal range (IQ\>85);
  • self-motivation to participate in the treatment both as regards the adolescent and the family;
  • availability of caregiver support the participant during the programme;
  • consent of the parents and the adolescent to participate in all evaluations and to be recorded during treatment sessions.

You may not qualify if:

  • presence of a concomitant major psychiatric disorder (e.g., schizophrenia bipolar disorder);
  • presence of oppositional/aggressive behaviour (outside the family context) family context);
  • presence of genetic syndromes associated with autism spectrum disorder.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Antonio Narzisi

Pisa, Italy, 56018, Italy

Location

MeSH Terms

Conditions

Neurodevelopmental DisordersAutism Spectrum DisorderAttention Deficit Disorder with Hyperactivity

Condition Hierarchy (Ancestors)

Mental DisordersChild Development Disorders, PervasiveAttention Deficit and Disruptive Behavior Disorders

Study Officials

  • Giovanni Cioni, Neurolgy

    IRCCS Fondazione Stella Maris

    STUDY DIRECTOR
  • Antonio Narzisi, Psychology

    IRCCS Fondazione Stella Maris

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
SEQUENTIAL
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
PhD

Study Record Dates

First Submitted

October 9, 2024

First Posted

October 15, 2024

Study Start

September 20, 2024

Primary Completion

December 31, 2025

Study Completion

December 31, 2025

Last Updated

April 1, 2026

Record last verified: 2026-03

Data Sharing

IPD Sharing
Will share

all IPD collected throughout the trial

Shared Documents
STUDY PROTOCOL, SAP, ICF, CSR
Time Frame
from 01-01-2026 for 5 years
Access Criteria
Writing a mail to principal investigator

Locations